tirzepatide rheumatoid arthritis GLP-1 Medications and Arthritis: What a New Study Shows GLP-1 Drugs May Reduce Inflammation

PMID: Summary Keywords GIP/GLP-1 receptor agonist, glucagon-like peptide 1 receptor agonist, glucocorticosteroids, semaglutide, steroid-induced diabetes, steroid-induced hyperglycaemia Citation Jdrasek A, Lisowska K and Czupryniak L (2026) Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review

Other Metabolic Benefits In the T2D trial, there were also dose-response reductions in HbA1c: retatrutide 12 mg reduced HbA1c by 2.16% at 36 weeks, corresponding to an estimated difference from dulaglutide 1.5 mg of -0.80% (95% CI: -1.16, -0.44)

GLP-1 drugs act on GLP-1 receptors throughout the body

Read more about the benefits of cold-pressed protein

Real world studies (2023-2024): The data shows that there is no rise in thyroid, pancreatic, or colon cancer seen to those who use semaglutide for diabetes or obesity